Siemens Healthineers has opened a $11.8 million (€10 million) research and development center in Swords, Ireland, focused on next-generation immunoassay laboratory instruments.

The new Centre of Excellence sits adjacent to the company’s existing manufacturing operations and expands its role in the global development of diagnostic platforms.

The site has already added more than 65 engineering roles spanning software, hardware, biosciences, data science, and AI, and will continue building out its workforce. The new facility will support ongoing work on Siemens Healthineers' Atellica portfolio of immunoassay and clinical chemistry analyzers, which are used in laboratories worldwide for high-volume testing across a range of conditions, including infectious diseases and cancer.
“This site has delivered world-class diagnostic instruments to hospitals and laboratories globally,” said Patrick Grimes, global head of hardware engineering R&D for Siemens Healthineers Diagnostics. “Now, by aligning research and development with production under one roof, we are accelerating the pace of discovery and delivery.”

The investment is part of a multiyear plan launched in 2023 and backed by IDA Ireland. Additional funding is expected in the coming years to expand R&D and sustainability initiatives.

Minister for Climate, Energy and the Environment Darragh O’Brien, who attended the opening, called the new facility “state-of-the-art,” adding, “The innovations and products developed here in Ireland will have a truly global reach.”

IDA Ireland CEO Michael Lohan described the center as “a significant milestone for Ireland’s med tech sector,” and said it “reinforces our position as a global hub for innovation in diagnostics and life sciences.”

In addition to the facility investment, Siemens Healthineers received a training and development grant from IDA Ireland to support a multiyear upskilling program aimed at strengthening technical and leadership capabilities within the company’s Irish workforce.

European News Homepage